Lonza Group Ltd (LONN) Stock Price Quote Today & Current Price Chart

Trade Lonza Group Ltd - LONN

Lonza Group AG (SWX: LONN) is a Swiss contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotech industries. Specializing in biologics, cell and gene therapies, and small molecule APIs, Lonza plays a critical role in scaling complex therapies. With long-term client contracts and global facilities, the company benefits from rising biotech outsourcing and specialty medicine demand. Lonza offers investors a high-quality life sciences supplier with resilient, innovation-led growth.

Latest shares articles

How to Analyse Apple Before Earnings

Apple’s quarterly results have generally been better than analyst forecasts, with EPS missing estimates only once over the last 21 quarters.

11 minutes ago

How to Analyse Meta Before Earnings

Earnings announcements can be among the most closely watched events for individual stocks. Alongside the financial results themselves, investors often monitor historical earnings performance, valuation metrics and options pricing to provide context for prior reporting periods.

21 minutes ago

Diginex stock forecast: Resulticks funding deadline extended

Diginex is a technology company focused on ESG and RegTech services, with recent updates centred on its proposed Resulticks acquisition and leadership changes. Explore third-party DGNX price targets and technical analysis. Past performance is not a reliable indicator of future results.

11:58, 14 July 2026

Vinci stock forecast: Third-party price targets

VINCI announced a German heavy-vehicle charging contract on 9 July 2026, adding to recent corporate updates as Vinci shares traded near €119.42. Explore third-party DG price targets and technical analysis. Past performance is not a reliable indicator of future results.

11:39, 14 July 2026

Related News